Lecture #4 – June 4, 2003
|
|
|
Population, Screening, and Guidelines |
|
Dr. Kunzel |
|
|
Population, Screening, and
Guidelines
|
|
|
|
To be familiar with the term
“screening” |
|
To recognize factors that make a
disease appropriate for screening |
|
To recognize the attributes of a good
screening test |
|
To assess oral ca as appropriate for
screening |
|
To assess oral ca exams as appropriate
for screening |
|
To consider the evidence base for oral
ca screening |
|
To consider barriers to performing oral
ca detection |
|
|
|
|
Screening –
a form of needs assessment
|
|
|
|
Screenings – |
|
Procedures that sort out persons who may have a condition |
|
from those who may not |
|
Those appearing to have the condition
are followed up |
|
to obtain a final diagnosis |
|
& tx as necessary |
Screening –
a form of needs assessment
|
|
|
|
|
|
3 types of screening |
|
1.
Population-based |
|
Define a population |
|
Endeavor to screen the entire
population |
|
2.
Targeted population |
|
Aim at a “high risk” segment of the
population |
|
Gender, age, behavior, health-related
characteristic |
|
3.
Opportunistic population |
|
-- Offer screening test for unsuspected disorder |
|
-- At time when person presents to clinician for another
reason |
|
|
Screening –
a form of needs assessment
|
|
|
|
What do we screen for? |
|
Presence of disease itself |
|
A risk factor for disease |
|
(“do you smoke?”) |
Screening –
a form of needs assessment
|
|
|
Dental Screenings |
|
Cursory oral inspections to provide estimates
of oral health status |
|
Typically a dentist or dental hygienist
inspects an individual’s mouth for obvious dental problems |
|
|
|
|
Screening –
a form of needs assessment
|
|
|
|
Dental Screenings |
|
Oral inspections |
|
can be done using tongue depressors |
|
and a simple light source, such as |
|
flashlight |
|
|
|
|
|
|
|
|
Slide 8
Screening -
a form of needs assessment
|
|
|
|
Dental Screenings |
|
Estimates urgency of need for dental
treatment |
|
using specific criteria |
|
Most often use the ADA’s criteria: |
|
Apparently requires no dental tx |
|
Requires tx but not of an urgent nature |
|
Requires early treatment |
|
Requires immediate treatment |
|
Must notify examinee (or parent) of
conditions that require follow-up |
|
|
|
|
"2 questions need to
ask"
|
|
|
2 questions need to ask: |
|
What makes a disease or risk factor
appropriate for screening? |
|
What are the attributes of a good
screening test? |
|
(Frankenburg criteria) |
Factors that make disease
approp-riate for screening
|
|
|
the disease is serious (mortality,
morbidity) |
|
the disease is treatable & accepted intervention exists |
|
early treatment is better than late
treatment |
|
the disease has a pre-clinical
detectable period |
|
the disease is prevalent in a tested
population |
Attributes of good screening
test
|
|
|
high sensitivity - ability of the test
to identify correctly those who have the disease |
|
high specificity - ability of the test
to identify correctly those who do not have the disease |
|
low risk (to patient) |
|
inexpensive or cost effective |
|
tolerable or acceptable to the public |
Attributes of good screening
test
|
|
|
|
high sensitivity - ability of the test
to identify correctly those who have the disease |
|
high specificity - ability of the test
to identify correctly those who do not have the disease |
|
|
|
Screenings - must evaluate against
some standard procedure for validity |
|
sensitivity, specificity |
|
Proportion false-positives and false
negatives |
|
important to patient follow-up and cost |
(Not) attributes of good
screening test
|
|
|
Adverse consequences of screening |
|
Misdiagnosis - further tests must be
taken if a false positive result obtained |
|
Labeling - costs associated with
telling someone have a disease |
|
Reinforcement of bad habits among some |
Attributes of good screening
test
|
|
|
low risk (to patient) |
|
inexpensive or cost effective |
|
tolerable or acceptable to the public |
|
|
|
Because screenings are applied to populations |
|
their methods must be simple |
|
inexpensive |
|
require minimal training for application & interpretation |
|
|
Attributes of good screening
test
|
|
|
|
Positive outcomes of screening |
|
Identification of high-risk groups for
interventions – |
|
it should be possible to differentiate those with the condition
from those at borderline or without |
|
Improved prognosis for individual
patients |
|
Reduced morbidity for cases treated
early |
|
Reduced incidence of disease |
|
Reduced mortality |
|
|
|
|
|
|
Early Oral Cancer Detection
|
|
|
Is oral cancer an appropriate target
for screening? |
Oral Ca as appropriate for
screening:
Early tx better than late tx?
|
|
|
|
Rationale for oral cancer based on
facts: |
|
Malignancies are asymptomatic and
localized for a period |
|
Sometimes takes number of years to
reach full invasive potential |
|
making intervention with progression of
an early lesion possible |
|
|
|
|
Oral Ca as appropriate for
screening:
Has a pre-clinical detectable period?
|
|
|
Often preceded by potentially malignant
lesions/ conditions such as leukoplakia, erythroplakia, and submucous
fibrosis |
|
Major sites of occurrence readily
accessible to examination |
|
|
|
|
Oral Ca as appropriate for
screening:
The disease is serious (mortality, morbidity)?
Early tx better than late tx?
|
|
|
|
Oral cancer has one of the lowest
five-year survival rates (52%) |
|
5-year survival rate for advanced cases
is 19 % |
|
vs. 78 % for localized lesions |
|
When detected early, prognosis for
survival better than for many other cancers |
Oral Ca as appropriate for
screening:
The disease is serious
(mortality, morbidity)?
|
|
|
Morbidity: |
|
Consequences of advanced oral cancers: |
|
- Chronic pain |
|
- Loss of function |
|
- Social disfigurement |
|
Sequelae often result in: |
|
- cosmetic/psychological insult |
|
- social
isolation |
Oral Ca as appropriate for
screening:
The disease is serious
(mortality, morbidity)?
The disease is prevalent in a tested population?
|
|
|
|
Mortality: |
|
Annually approximately 30,000 Americans
are diagnosed with oral cancers |
|
1995 - 28,000 new cases |
|
1995 - 8,400 deaths |
|
Incidence greater than leukemia, |
|
Hodgkin’s disease |
|
cancer of the brain, liver, bone |
|
thyroid gland, stomach, or cervix |
Oral Ca as appropriate for
screening:
The disease is
prevalent in a tested population?
|
|
|
|
|
In the west, incidence is relatively
low |
|
Largest study group was over 23,000
adults > age 30 in MN |
|
Mouths examined between 1957 and 1972 |
|
More than 10% of the screened had an
oral lesion |
|
But were mostly benign: |
|
precancer encountered in 2.9% |
|
cancer in less than 0.1% |
Oral Ca as appropriate for
screening:
The disease is
prevalent in a tested population?
|
|
|
|
Annual incidence of oral cancer in the
U.S.: |
|
11/100,000 population |
|
with a male/female ratio greater than
2:1 |
|
Responsible for 2% of all cancer deaths
in the U.S. |
"Is an oral cancer
examination..."
|
|
|
Is an oral cancer examination a “good’
screening test? |
Oral Ca exam as appropriate
for screening
|
|
|
Principal screening test for oral
cancer in asymptomatic persons |
|
Involves visual exam of oral cavity and
extraoral areas using a dental mirror |
|
Retracting tongue with a gauze pad to
view hard-to-see areas |
|
Also digital palpation with a gloved
hand for masses |
Oral Ca exam as appropriate
for screening
Low risk to patient?
Tolerable or acceptable to the public?
Inexpensive or cost effective?
|
|
|
|
Screening examination is
inexpensive,safe |
|
Noninvasive, quick, well tolerated |
|
Recently published results |
|
large multicenter double-blind study |
|
suggest the potential efficacy of using the oral brush biopsy |
|
to increase detection of early stage oral cancer and precancerous
lesions |
|
assuming dentists provide complete oral cancer exams on regular basis |
|
|
Oral Ca exam as appropriate
for screening
Inexpensive or cost effective?
|
|
|
Insufficient evidence of cost
effectiveness |
|
In high incidence part of the
world: |
|
Substantial proportion of suspicious
lesions found (2-16% in south Asia) |
|
But compliance of patients to attend
follow up was poor |
Oral Ca exam as appropriate
for screening
Inexpensive or cost effective?
|
|
|
|
Screenings – patient compliance very
impt |
|
Procedures that sort out persons who
may have a condition |
|
from those who may not |
|
Those appearing to have the condition
must be followed up |
|
to obtain a final diagnosis |
|
& tx as necessary |
Oral Ca exam as appropriate
for screening
Inexpensive or cost effective?
|
|
|
Stronger case can be made for targeting
screening to “at risk” populations |
|
smokers |
|
heavy drinkers > age of 40 |
|
|
|
But still problems of attendance at
initial exam (patient compliance) |
|
plus low disease prevalence |
|
make this of uncertain utility |
Oral Ca exam as appropriate
for screening
Inexpensive or cost effective?
|
|
|
|
Some evidence for effectiveness of
opportunistic screening |
|
Oral Cancer Case Finding Program in
Cuba |
|
Between 1983 and 1990, 10,167,999
patients were screened when they attended clinics |
|
only 27% with suspect lesions complied
with referral |
|
of these, 3220 potentially malignant
lesions |
|
581 squamous cell carcinomas |
|
127 other malignancies |
Oral Ca exam as appropriate
for screening
Inexpensive or cost effective?
|
|
|
|
Some evidence for effectiveness of
opportunistic screening |
|
Oral Cancer Case Finding Program in
Cuba (cont.) |
|
Program was shown to be effective: |
|
“downstaging” of cancers seen: |
|
Stage I lesions rising from 22.8% to
48.2% |
|
Stage II, III, and IV lesions falling
from 77.2% to 51.8% |
Evidence base for oral ca
screening
|
|
|
|
Exam validity – its ability to
differentiate: |
|
those with the condition from those at
borderline or without |
|
Patient outcomes |
|
Improved prognosis for individual
patients |
|
Reduced morbidity for cases treated
early |
|
Reduced incidence of disease |
|
Reduced mortality |
|
|
|
|
|
|
Evidence base for oral
cancer screening
|
|
|
|
Population screening for oral ca cannot
be recommended because: lack evidence
of its validity: |
|
Principal screening test in
asymptomatic persons is inspection and palpation of the oral cavity |
|
Its sensitivity is unknown |
|
Little information on the frequency
of false positives |
|
|
Evidence base for oral
cancer screening
|
|
|
|
Population screening for oral ca cannot
be recommended because: lack evidence
of its effectiveness: |
|
No controlled trials of screening for
oral cancer that include data on clinical outcomes |
|
Consistent evidence that persons with
early-stage oral cancer have a better prognosis than those diagnosed with
more advanced disease |
|
But may be due to possible effects of
lead-time and length bias |
Evidence base for oral
cancer screening
|
|
|
Lead-time bias |
|
Survival can appear to be lengthened: |
|
when screening simply advances earlier
the time of diagnosis, |
|
lengthening the period of time between
dx and death |
|
without any true prolongation of life |
Evidence base for oral
cancer screening
|
|
|
|
Length bias |
|
Tendency of screening to detect a
dispro-portionate # of cases of slowly progressive disease |
|
and to miss aggressive cases that, by virtue of rapid
progression, are present in the population only briefly |
|
Aggressive malignancies will be
under-represented in the cases found |
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
Report of the U.S. Preventive Services
Task Force, 2nd ed., 1996: |
|
Insufficient evidence to recommend for
or against routine screening of asymptomatic persons for oral ca by primary
care clinicians. |
|
Although direct evidence lacking,
clinicians may wish to include an exam for oral ca in the periodic health
exam of persons who chew or smoke
tobacco, older persons who drink regularly, anyone with suspicious symptoms |
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
Report of the U.S. Preventive Services Task Force, 2nd ed., 1996
(cont.) |
|
All patients, especially those at
increased risk… |
|
should be advised to receive a complete dental examination on a regular basis. |
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
|
Report of the U.S. Preventive Services
Task Force, 2nd ed., 1996 (cont.) |
|
Routine oral exam by primary care
clinicians |
|
Level of evidence: III |
|
Strength of recommendation: C |
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
Report of the U.S. Preventive Services
Task Force, 2nd ed., 1996 (cont.) |
|
I: Evidence from at least 1 properly
random- ized controlled trial |
|
II-1: …from well-designed controlled
trials w/o randomization |
|
II-2: …from well-designed cohort or
case-control analytic studies from >1 research grp |
|
II-3: …from multiple time series w/ or
w/o the intervention (dramatic results, e.g., penicillin) |
|
III:
Experts, experience, case reports |
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
Report of the U.S. Preventive Services
Task Force, 2nd ed., 1996 (cont.) |
|
A: Good evidence to support the rec
that condition be considered in periodic hlth exam |
|
B: Fair evidence to support rec that be
specifically considered |
|
C: Insufficient evidence to rec for or
against the inclusion of the condition, but rec may be made on other grounds |
|
D: Fair evidence to support the rec
that be excluded |
|
E: Good evidence to support the rec
that be |
|
excluded |
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
American Cancer Society |
|
|
|
Recommends a cancer checkup |
|
that includes oral exam every 3 years for persons over 20 |
|
and annually for those over age 40 |
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
|
Canadian Task Force on Periodic Health
Examination |
|
Concluded was insufficient evidence to
include/ exclude screening of oral ca |
|
in periodic health exams |
|
of persons in the general population |
|
but suggested |
|
annual oral exam |
|
for persons over 60 at risk |
|
|
|
|
Evidence base for oc
screening
Clinical Practice Guidelines
|
|
|
Logically such examinations dentists
are providers of choice to perform |
|
But is need for other health care
providers to assume more responsibility |
Population, Screening, and
Guidelines
|
|
|
|
To be familiar with the term
“screening” |
|
To recognize factors that make a
disease appropriate for screening |
|
To recognize the attributes of a good
screening test |
|
To assess oral ca as appropriate for
screening |
|
To assess oral ca exams as appropriate
for screening |
|
To consider the evidence base for oral
ca screening |
|
To consider barriers to performing oral
ca detection |
|
|
|
|
"Barriers to early oral
cancer..."
|
|
|
Barriers to early oral cancer detection
- how to confront? |
To consider barriers to performing oral ca detection
|
|
|
|
A review of several studies assessing
oral cancer knowledge, opinions, and practices suggests: |
|
many MDs and DDS do not detect oral
lesions in their early stages |
|
because of inappropriate attitudes or
lack of knowledge |
To consider barriers to performing oral ca detection
|
|
|
A recent pilot survey of MD and DDS’
knowl, opinions, practices- |
|
Found that 34% of DDS and 37% of MDs
did not recognize the importance of early detection as means of reducing
morbidity and mortality from these diseases |
|
|
To consider barriers to performing oral ca detection
|
|
|
Studies report MDs do not routinely
inspect their pts to identify early, suspicious oral lesions |
|
77% of pts first diagnosed with oral ca
at an advanced stage under the routine care of a MD within past 3-24 months |
|
Another study - 94% of pts with
advanced oral ca seen by a MD within 1 year of dx |
To consider barriers to performing oral ca detection
|
|
|
DDS also remiss in early dx and
referral for oral cancer |
|
Reported that 14% of DDS performed all
aspects of an intraoral exam |
|
Studies span 3 decades, yet results
unchanged |
|
DDS missed approx twice as many
asymptomatic oral ca as they found |
|
Failed to recognize oral ca in 69% of
cases presented to them |
|
|
|
|